Calcified Tissue International

, Volume 55, Issue 3, pp 198–203 | Cite as

Androgen resistance and deficiency have different effects on the growing skeleton of the rat

  • D. Vanderschueren
  • E. Van Herck
  • P. Geusens
  • A. Suiker
  • W. Visser
  • K. Chung
  • R. Bouillon
Laboratory Investigations

Abstract

Mature male, female, and androgen-resistant testicular feminized (Tfm) male rats of the same strain were sacrificed at the age of 120 days. Young male and Tfm rats were orchidectomized (orch) at 1 month of age and sacrificed at 120 days. The right femora were dissected, cleaned, defatted, and scanned with the Hologic QDR-1000. Orch and Tfm rats had similar body weights that were intermediate between body weights of their normal male and female littermates. Serum IGF-I concentrations were lowest in Tfm rats; IGF-1 concentrations in orch rats were not lower than in males. Dual-energy X-ray absorptiometry yielded the following results: Total femoral mass and area were lower in female, Tfm rats and in both orch groups compared with intact male rats. Femoral bone density was, however, only decreased in orch rats. Bone density measured in an area containing only cortical bone was not different between groups. However, the density was lower in orch rats in an area containing both cancellous and cortical bone. This finding is consistent with a ±50% decrease of cancellous bone volume in orch rats compared with all other groups at the proximal tibial metaphysis (an area containing mainly cancellous bone). These data show that Tfm rats, despite having lower IGF-I levels in serum, low body weight, and decreased femoral areas, manage—in contrast with orchidectomized rats—to maintain similar trabecular bone densities and volumes during growth. We conclude that trabecular bone densities can be preserved in androgen-resistant male rats independent of bone or body growth velocity or IGF-I secretion. We postulate that the modest increase of estrogen concentration in this animals and/or in situ aromatization may be responsible for the maintenance of the cancellous bone.

Key words

Growth Androgens Dual-energy X-ray absorptiometry 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Smith DAS, Walker MS (1977) Changes in plasma steroids and bone density in Klinefelter's syndrome. Calcif Tissue Res 22: 225–229Google Scholar
  2. 2.
    Horowitz M, Wishart JM, O'Loughin PD, Morris HA, Need AG, Nordin BEC (1992) Osteoporosis and Klinefelter's syndrome. Clin Endocrinol 36:113–118Google Scholar
  3. 3.
    Wong FHW, Pun KK, Wang C (1993) Loss of bone mass in patients with Klinefelter's syndrome despite sufficient testosterone replacement. Osteoporosis Int 3:3–7Google Scholar
  4. 4.
    Greenspan SL, Neer RM, Ridgway C, Klibanski A (1986) Osteoporosis in men with hyperprolactinemic hypogonadism. Ann Int Med 104:777–782Google Scholar
  5. 5.
    Finkelstein JS, Klibanski A, Neer RM, Doppelt SH, Rosenthal DI, Segre GV, Crowley WF Jr (1989) Increases in bone density during treatment of men with hypogonadotropic hypogonadism. J Clin Endocrinol Metab 69:776–783Google Scholar
  6. 6.
    Devogelaer JP, Decooman S, Dedeuxchaines CN (1992) Low bone mass in hypogonadal males. Maturitas 15:17–27Google Scholar
  7. 7.
    Francis RM, Peacock M, Aaron JE, Selby PI, Taylor GA, Thompson J, Marshall DH, Horsman A (1986) Osteoporosis in hypogonadal men: role of decreased plasma 1,25-dihydroxyvitamin D, calcium malabsorption and low bone formation. Bone 7:261–268Google Scholar
  8. 8.
    Stepan JJ, Lachman M, Zverina J, Pacovscky V, Baylink DJ (1989) Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab 69:523–527Google Scholar
  9. 9.
    Goldray D, Weisman Y, Jaccard N, Merdler C, Chen J, Martin H (1993) Decreased bone density in elderly men treated with the gonadotropin-releasing hormone agonist Decapeptyl. J Clin Endocrinol 76:288–290Google Scholar
  10. 10.
    Finkelstein JS, Neer RM, Biller BMK, Crawford JD, Klibanski A (1992) Osteopenia in men with a history of delayed puberty. N Engl J Med 326:600–604Google Scholar
  11. 11.
    Keenan BS, Richards GE, Ponder SW, Dallas JS, Nagamani M, Smith ER (1993) Androgen-stimulated pubertal growth: the effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty. J Clin Endocrinol Metab 75:996–1001Google Scholar
  12. 12.
    Jansson J-O, Eden S, Isaksson O (1985) Sexual dimorphism in the control of growth hormone secretion. Endocrin Rev 6:128Google Scholar
  13. 13.
    Gilsanz V, Roe TF, Gibbens DT, Schultz EE, Carlson ME, Gonzalez O, Boechat MI (1988) Effect of sex steroids on peak bone density in growing rabbits. Am J Physiol 255:E416-E421Google Scholar
  14. 14.
    Colvard DS, Eriksen EF, Keeting PE, Wilson EM, Lubahn DB, French FS, Riggs BL, Spelsberg TC (1989) Identification of androgen receptors in normal human osteoblast-like cells. Proc Natl Acad Sci USA 86:854–857Google Scholar
  15. 15.
    Benz DJ, Haussler, Thomas MA, Speelman B, Komm BS (1991) High-affinity androgen binding and androgenic regulation of alfa(I)-procollagen and transforming growth factor-β steady state messenger ribonucleic acid levels in human osteoblast-like osteosarcoma cells. Endocrinology 128:2723–2730Google Scholar
  16. 16.
    Masuyama A, Ouchi Y, Sato F, Hosoi T, Nakamura T, Orimo H (1992) Characteristics of steroid hormone receptors in cultured MC3T3-E1 osteoblastic cells and effect of steroid hormones on cell proliferation. Calcif Tissue Int 51:376–381Google Scholar
  17. 17.
    Schweikert HU, Rulf W, Niederle N, Schafter, Keck E, Kruck F (1980) Testosterone metabolism in human bone. Acta Endocrinol (Copenh) 95:258–264Google Scholar
  18. 18.
    Kasperk C, Wegedal JE, Farley JR, Linkhart TA, Turner RT, Baylink D (1989) Androgens directly stimulate proliferation of bone cells in vitro. Endocrinology 124:1576–1579Google Scholar
  19. 19.
    Kasperk C, Fitzsimmons R, Strong D, Mohan S, Jennings J, Wegedal J, Baylink D (1990) Studies of the mechanism by which androgens enhance mitogenesis and differentiation in bone. J Clin Endocrinol Metab 71:1322–1329Google Scholar
  20. 20.
    Pilbeam CC, Raisz LG (1990) Effects of androgens on parathyroid and interleukin-1-stimulated prostaglandin production in cultured neonatal mouse calvariae. J Bone Miner Res 5:1183–1188Google Scholar
  21. 21.
    Purohit A, Flanagan AM, Reed MJ (1992) Estrogen synthesis by osteoblast cell lines. J Clin Endocrinol Metab 61:152–157Google Scholar
  22. 22.
    Vanderschueren D, Van Herck E, Suiker AMH, Visser WJ, Geussens P, Schot LPC, Bouillon R, Rush EB, Einhorn TA (1993) Bone and mineral metabolism in the androgen-resistant (testicular feminized) male rat. J Bone Miner Res 8:799–807Google Scholar
  23. 23.
    Vanderschueren D, Van Herck E, Suiker AMH, Visser WJ, Schot LPC, Bouillon R (1992) Bone and mineral metabolism in aged male rats: short- and long-term effects of androgen deficiency. Endocrinology 130:2906–2916Google Scholar
  24. 24.
    Lips P, Asscheman H, Uitewaal P, Netenbos JC, Gooren L (1989) The effect of cross-gender hormonal treatment on bone metabolism in male-to-female transsexuals. J Bone Miner Res 4:657–662Google Scholar
  25. 25.
    Yarbrough WG, Quarmby VE, Simental JA, Joseph MS, Madhabananda S, Lubahn DB, Olsen KL, French FS, Wilson EM (1990) A single base mutation in the androgen receptor gene causes androgen insensitivity in the testicular feminized rat. J Biol Chem 265:8893–8900Google Scholar
  26. 26.
    Weisman Y, Cassorla F, Malozowski S, Krieg RJ, Goldray D, Kaye AM, Somjen D (1993) Sex-specific response of bone cells to gonadal steroids: modulation in perinatally androgenized females and testicular feminized male rats. Steroids 58:126–133Google Scholar
  27. 27.
    Vanderschueren D, Van Herck E, Schot L, Rush E, Einhorn T, Geusens P, Bouillon R (1993) The aged male rat as a model for human osteoporosis: evaluation by nondestructive measurements and biomechanical testing. Calcif Tissue Int 53:342–348Google Scholar
  28. 28.
    Amman P, Rizolli R, Slosman D, Bonjour SP (1992) Sequential and precise in vivo measurement of bone mineral density in rats using Dual-energy X-ray absorptiometry. J Bone Miner Res 7: 311–316Google Scholar
  29. 29.
    Slosman DO, Rizzoli R, Buchs B, Piana F, Donath A, Bonjour JP (1990) Comparative study of the performances of x-ray and gadolinium 153 bone densitometers at the level of the spine, femoral neck and femoral shaft. Eur J Nucl Med 17:3–9Google Scholar
  30. 30.
    Verhaeghe J, Van Herck E, Visser WJ, Suiker AMH, Thomasset M, Einhorn TA, Faierman E, Bouillon R (1990) Bone and mineral metabolism in BB- rats with long-term diabetes. Decreased bone turnover and osteoporosis. Diabetes 39:477–482Google Scholar
  31. 31.
    Verhaeghe J, Suiker AMH, Nyomba BL, Visser WJ, Einhorn TA, Dequeker J, Bouillon R (1989) Bone mineral homeostasis in spontaneously diabetic BB rats 2. Impaired bone turnover and decreased osteocalcin synthesis. Endocrinology 124:573–528Google Scholar
  32. 32.
    Turner RT, Hannon KS, Demers LM, Buchanan J, Bell NH (1989) Differential effects of gonadal function on bone histomorphometry in male and female rats. J Bone Miner Res 4:557–563Google Scholar
  33. 33.
    Schoutens A, Verhas M, L'Hermite-Baleriaux M, L'Hermite M, Verschaeren A, Dourov N, Mone M, Heilporn A, Tricot A (1984) Growth and bone haemodynamic responses to castration in male rats. Reversibility by testosterone. Acta Endocrinol 107:428–432Google Scholar
  34. 34.
    Saville PD (1969) Changes in skeletal mass and fragility with castration in the rat: a model for osteoporosis. J Am Geriatr Soc 17:155–166Google Scholar
  35. 35.
    Millard WJ, Politch JA, Martin JB, Fox TO (1986) Growth hormone secretory patterns in androgen-resistant (testicular feminized) rats. Endocrinology 119:2655–2680Google Scholar
  36. 36.
    Eriksen EF, Colvard DS, Berg NJ, Graham ML, Mann KG, Spelsberg TC, Riggs BL (1988) Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241:84–86Google Scholar
  37. 37.
    Girasole G, Jilka RL, Passeri G, Scott B, Boder G, Williams DC, Manolagas SC (1992) Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro. A potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 89:883–891Google Scholar
  38. 38.
    Kimmel DB, Wronski TJ (1990) Nondestructive measurements of bone mineral in ovariectomized rats. Calcif Tissue Int 46: 101–110Google Scholar
  39. 39.
    Griffin MG, Kimble R, Hopfer W, Pacifici R (1993) Dual-energy X-ray absorptiometry of the rat: accuracy, precision, and measurement of bone loss. J Bone Miner Res 8:795–800Google Scholar
  40. 40.
    Wink CS, Felts WJL (1980) Effects of castration on the bone structure of male rats: a model for osteoporosis. Calcif Tissue Int 32:77–82Google Scholar

Copyright information

© Springer-Verlag New York Inc. 1994

Authors and Affiliations

  • D. Vanderschueren
    • 1
  • E. Van Herck
    • 1
  • P. Geusens
    • 2
  • A. Suiker
    • 3
  • W. Visser
    • 3
  • K. Chung
    • 4
  • R. Bouillon
    • 1
  1. 1.Laboratorium voor Experimentele Geneeskunde en EndocrinologieKatholieke Universiteit LeuvenBelgium
  2. 2.Reumatologie, U.Z. PellenbergKatholieke Universiteit LeuvenBelgium
  3. 3.Dienst Botpathologie, A.Z.UtrechtThe Netherlands
  4. 4.Health Science CenterOklahoma CityUSA

Personalised recommendations